These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33630303)

  • 1. FGF21: a promising therapeutic agent for alcoholic cardiomyopathy?
    Romanello V
    J Pathol; 2021 Jul; 254(3):213-215. PubMed ID: 33630303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effect of fibroblast growth factor-21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function.
    Ferrer-Curriu G; Guitart-Mampel M; Rupérez C; Zamora M; Crispi F; Villarroya F; Fernández-Solà J; Garrabou G; Planavila A
    J Pathol; 2021 Feb; 253(2):198-208. PubMed ID: 33125701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease.
    Ferrer-Curriu G; Redondo-Angulo I; Guitart-Mampel M; Ruperez C; Mas-Stachurska A; Sitges M; Garrabou G; Villarroya F; Fernández-Solà J; Planavila A
    J Pathol; 2019 May; 248(1):30-40. PubMed ID: 30582148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of fibroblast growth factor 21 in diabetic cardiomyopathy.
    Zhang X; Yang L; Xu X; Tang F; Yi P; Qiu B; Hao Y
    Heart Fail Rev; 2019 Nov; 24(6):1005-1017. PubMed ID: 31175491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of FGF21 in the pathogenesis of cardiovascular disease.
    Zhang Y; Liu D; Long XX; Fang QC; Jia WP; Li HT
    Chin Med J (Engl); 2021 Dec; 134(24):2931-2943. PubMed ID: 34939977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF21-FGFR1 controls mitochondrial homeostasis in cardiomyocytes by modulating the degradation of OPA1.
    Yan B; Mei Z; Tang Y; Song H; Wu H; Jing Q; Zhang X; Yan C; Han Y
    Cell Death Dis; 2023 May; 14(5):311. PubMed ID: 37156793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury.
    Desai BN; Singhal G; Watanabe M; Stevanovic D; Lundasen T; Fisher FM; Mather ML; Vardeh HG; Douris N; Adams AC; Nasser IA; FitzGerald GA; Flier JS; Skarke C; Maratos-Flier E
    Mol Metab; 2017 Nov; 6(11):1395-1406. PubMed ID: 29107287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection from alcohol intoxication: Must be FGF21 to enter.
    Jastroch M; Keipert S; Tschöp MH
    Cell Metab; 2023 Mar; 35(3):377-379. PubMed ID: 36889276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation.
    Yan X; Chen J; Zhang C; Zhou S; Zhang Z; Chen J; Feng W; Li X; Tan Y
    J Cell Mol Med; 2015 Jul; 19(7):1557-68. PubMed ID: 25823710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy.
    Rupérez C; Lerin C; Ferrer-Curriu G; Cairo M; Mas-Stachurska A; Sitges M; Villarroya J; Giralt M; Villarroya F; Planavila A
    Int J Cardiol; 2018 Jun; 260():163-170. PubMed ID: 29519677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 21 controls mitophagy and muscle mass.
    Oost LJ; Kustermann M; Armani A; Blaauw B; Romanello V
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):630-642. PubMed ID: 30895728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 21 inhibition aggravates cardiac dysfunction in diabetic cardiomyopathy by improving lipid accumulation.
    Chen C; Meng Z; Zheng Y; Hu B; Shen E
    Exp Ther Med; 2018 Jan; 15(1):75-84. PubMed ID: 29375676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice.
    Wu F; Wang B; Zhang S; Shi L; Wang Y; Xiong R; Pan X; Gong F; Li X; Lin Z
    Clin Sci (Lond); 2017 Aug; 131(15):1877-1893. PubMed ID: 28559425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fibroblast growth factor 21 in atherosclerosis.
    Kokkinos J; Tang S; Rye KA; Ong KL
    Atherosclerosis; 2017 Feb; 257():259-265. PubMed ID: 28012645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcoholic cardiomyopathy: pathophysiologic insights.
    Piano MR; Phillips SA
    Cardiovasc Toxicol; 2014 Dec; 14(4):291-308. PubMed ID: 24671642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 21 protects the heart from oxidative stress.
    Planavila A; Redondo-Angulo I; Ribas F; Garrabou G; Casademont J; Giralt M; Villarroya F
    Cardiovasc Res; 2015 Apr; 106(1):19-31. PubMed ID: 25538153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
    Woo YC; Xu A; Wang Y; Lam KS
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):489-96. PubMed ID: 23134073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 21 in non-alcoholic fatty liver disease.
    Tucker B; Li H; Long X; Rye KA; Ong KL
    Metabolism; 2019 Dec; 101():153994. PubMed ID: 31672443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.